explore -WSS

explore

author：Wikipedia 2025-10-02 18:46:47 - browse：3959

A syringe injects into a segment of DNA — biotech coverage from STAT — Adobe

Two congenitally deaf children can hear for the first time after being treated with gene therapy, according to data presented at a conference Wednesday.

The results are “jaw-droppingly good, just shocking how good. It exceeded the wildest expectations of anybody who started this work,” said Larry Lustig, an otolaryngologist at Columbia University and an investigator on the study.

The new data come from a larger study by Regeneron Pharmaceuticals that will treat nearly two dozen children with a specific type of congenital hearing loss with gene therapy. The clinical trial is meant to measure safety and efficacy of DB-OTO, a gene therapy drug Regeneron is developing to treat children who have hearing loss due to changes in the otoferlin gene. Several teams are targeting this rare form of congenital deafness that affects 1% to 8% of deaf people globally, including a team with Akouos, an Eli Lilly subsidiary, which successfully treated an 11-year-old boy with a similar gene therapy. Lustig calls this the “lowest of the low-hanging fruit” for gene therapy deafness treatments.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： FDA approves updated Covid vaccines

hotspot

WSS

American woman, child freed after being kidnapped in Haiti last month

How housing is health care on Long Island

How to make the FDA’s new prescription one

Food makers tried to stack nutrition panel with preferred experts

Wegovy trial has doctors encouraged over new possibilities

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

hotspot

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Jerome Adams on the need for new antivirals for Covid

Why failed clinical trials don’t always spell doom for a new drug

Trump demands the U.S. pay no more for drugs than other countries … again

Drastic changes should bring profitability, startup health insurers say

Jerome Adams on the need for new antivirals for Covid

The best solution to the drug shortages problem

Wildfire smoke exposes gaps in outdoor worker protections

WATCH: Why do bright lights make us see spots?

New air purifier tech could be key to improving indoor air quality

American woman, child freed after being kidnapped in Haiti last month

focus

What to know about Virgin Galactic's 1st mission taking paying customers to space

FDA approves updated Covid vaccines

FDA panel issues narrow recommendation for Covid vaccine booster doses

Methadone doses haven’t kept up in the age of fentanyl

American woman, child freed after being kidnapped in Haiti last month

A common UTI test for kids haunts adults as a traumatic 'nightmare'

knowledge

hotspot

Wikipedia

hotspot